SCHEMBL30916073

SCHEMBL30916073

Cc1cccc(C[C@H](COc2ccc3ncc(F)cc3c2C(=O)OCc2ccccc2)NC(=O)OC(C)(C)C)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 1/20 0.37
▸ AAK1 Q2M2I8 4/20 0.36
▸ HDAC3 O15379 4/20 0.35
▸ HDAC4 P56524 4/20 0.35
▸ HDAC1 Q13547 4/20 0.35
▸ HDAC7 Q8WUI4 4/20 0.35
▸ HDAC2 Q92769 4/20 0.35
▸ HDAC10 Q969S8 4/20 0.35
▸ HDAC11 Q96DB2 4/20 0.35
▸ HDAC8 Q9BY41 4/20 0.35
▸ HDAC6 Q9UBN7 4/20 0.35
▸ HDAC9 Q9UKV0 4/20 0.35
▸ HDAC5 Q9UQL6 4/20 0.35
▸ ATM Q13315 2/20 0.35
▸ JAK2 O60674 2/20 0.34
▸ PLA2G2A P14555 1/20 0.34
▸ DHODH Q02127 1/20 0.34
▸ CTSS P25774 1/20 0.34
▸ CTSK P43235 1/20 0.34
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30916034 0.90 HDAC3 (0.36) SYKAAK1HDAC3HDAC4HDAC1
SCHEMBL30790785 0.90 ATM (0.43) SYKAAK1HDAC3HDAC4HDAC1
SCHEMBL30916027 0.87 SYK (0.41) SYKAAK1HDAC3HDAC4HDAC1
SCHEMBL30916020 0.87 SYK (0.41) SYKAAK1HDAC3HDAC4HDAC1
SCHEMBL30916090 0.86 HDAC3 (0.37) SYKAAK1HDAC3HDAC4HDAC1
Hydrochloric Acid SCHEMBL30916045 0.84 DHODH (0.38) PLA2G2ADHODHMAPTMAPK1HSD17B10
SCHEMBL29097022 0.79 ATM (0.43) SYKAAK1HDAC3HDAC4HDAC1
SCHEMBL29097024 0.79 ATM (0.43) SYKAAK1HDAC3HDAC4HDAC1
SCHEMBL29828533 0.79 ATM (0.43) SYKAAK1HDAC3HDAC4HDAC1
SCHEMBL30878142 0.78 ATM (0.47) SYKATMCTSSCTSKMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260098060-A1 MACROCYCLIC CFTR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2026-04-09 — — US disclosed
EP-4587443-A1 MACROCYCLIC CFTR MODULATORS Idorsia Pharmaceuticals Ltd (CH) 2025-07-23 — — EP disclosed
WO-2024056798-A1 MACROCYCLIC CFTR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-03-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260098060-A1 MACROCYCLIC CFTR MODULATORS CFTR, CLIC1, ARRB1 SYK 3578/4885AAK1 2966/4885HDAC3 1311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback